For Some Device Companies, Europe Suddenly Seems Less Inviting
Executive Summary
Some device executives have begun to argue that the "Europe first" strategy, whereby device companies being their marketing efforts in Europe, may not be all it's cracked up to be. Adoption ramps up quickly, say some, but only among a handful of leading, innovative clinicians--and then hits a wall, thanks to conservative clinical cultures in many countries.
You may also be interested in...
QUOTED. 29 May 2020. Alison Hunt.
New data seems to indicate an uptick in the percentage of premarket applications that receive a major deficiency letter. See what US FDA spokesperson Alison Hunt said about strategies to avoid them.
Takeda Culls Shunned Ex-Shire Asset After EC Lifts Antimonopoly Concerns
Japanese firm says it will end SHP647 development after trying unsuccessfully to find takers for GI drug similar to its blockbuster Entyvio, first flagged by European authorities over competition worries.
J&J’s Baby Powder Announcement Renews NGO Calls For Industry, FDA To End Use Of Talc In Cosmetics
The Environmental Working Group and US PIRG suggest that beauty and personal-care firms should avoid using talc in loose powders, if not all cosmetic products, and that the US FDA should consider banning the ingredient due to the potential for asbestos contamination, among other concerns.
Need a specific report? 1000+ reports available
Buy Reports